Publications by the researcher in collaboration with Nerea Bitarte Manzanal (21)

2013

  1. Valoración de marcadores pronósticos de respuesta a bevacizumab en pacientes con cáncer colorrectal avanzado y su utilidad para la individualización del tratamiento

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 1, pp. 174-177

2012

  1. Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 12, pp. 1774-1780

  2. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array

    World Journal of Gastroenterology, Vol. 18, Núm. 7, pp. 637-645

  3. Identification of predictive circulating biomarkers of bevacizumab- containing regimen efficacy in pre-treated metastatic colorectal cancer patients

    British Journal of Cancer, Vol. 107, Núm. 2, pp. 287-290

2011

  1. Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

    European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847

  2. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

    Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671

2010

  1. Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535

  2. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): A dose-finding study and pharmacogenomic analysis

    British Journal of Cancer, Vol. 102, Núm. 6, pp. 987-994

  3. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation

    Molecular Cancer Therapeutics, Vol. 9, Núm. 8, pp. 2265-2275

2009

  1. Colorectal Carcinoma: Identification of MicroRNAs Using Real-Time Polymerase Chain Reaction

    METHODS OF CANCER DIAGNOSIS, THERAPY, AND PROGNOSIS, VOL 4 (SPRINGER), pp. 83-102

  2. Epigenetic regulation of microRNA expression in colorectal cancer

    International Journal of Cancer, Vol. 125, Núm. 11, pp. 2737-2743

  3. Farmacogenómica en cáncer

    Biología molecular en cáncer: aproximación a las nuevas terapias (Barcelona : Prous Sciencie, D.L. 2009), pp. 157-177

  4. Nuevos horizontes en RNA: microRNA y RNA de interferencia

    Biología molecular en cáncer: aproximación a las nuevas terapias (Barcelona : Prous Sciencie, D.L. 2009), pp. 65-87

  5. Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

    EJC SUPPLEMENTS

  6. Vías moleculares de la angiogénesis tumoral

    Biología molecular en cáncer: aproximación a las nuevas terapias (Barcelona : Prous Sciencie, D.L. 2009), pp. 741-764

  7. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions

    European Journal of Cancer, Vol. 44, Núm. 17, pp. 2689-2695

  2. Individualizing therapy in colorectal cancer: Current approaches in pharmacogenomics

    Cancer and Chemotherapy Reviews, Vol. 3, Núm. 3, pp. 161-174

2007

  1. Expression of microRNA-451 is associated with disease-free survival in gastric cancer patients treated with chemoradiotherapy after gastric resection

    EJC SUPPLEMENTS

  2. Moving forward in colorectal cancer research, what proteomics has to tell

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5813-5821